{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T13:50:08Z","timestamp":1710510608916},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,5]]},"DOI":"10.7759\/cureus.23858","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T02:27:18Z","timestamp":1649212038000},"source":"Crossref","is-referenced-by-count":2,"title":["A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient"],"prefix":"10.7759","author":[{"given":"Nathan","family":"DeRon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maheen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Alobaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2008-0236","article-title":"Primary CNS lymphoma in immunocompetent patients","volume":"14","author":"Sierra del Rio M","year":"2009","unstructured":"Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K. Primary CNS lymphoma in immunocompetent patients. Oncologist. 2009, 14:526-39. 10.1634\/theoncologist.2008-0236","journal-title":"Oncologist"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520937839","article-title":"A case report of primary central nervous system lymphoma","volume":"48","author":"Zeng X","year":"2020","unstructured":"Zeng X, Lu X, Li X, Peng L, Chen L. A case report of primary central nervous system lymphoma. J Int Med Res. 2020, 48:300060520937839. 10.1177\/0300060520937839","journal-title":"J Int Med Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008377","article-title":"Primary central nervous system lymphoma","author":"Schaff LR","year":"2021","unstructured":"Schaff LR, Grommes C. Primary central nervous system lymphoma. Blood. 2021, 10.1182\/blood.2020008377","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2171","article-title":"Central nervous system lymphoma: characteristic findings on traditional and advanced imaging","volume":"32","author":"Haldorsen IS","year":"2011","unstructured":"Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol. 2011, 32:984-92. 10.3174\/ajnr.A2171","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14073","article-title":"Trends in primary central nervous system lymphoma incidence and survival in the U.S","volume":"174","author":"Shiels MS","year":"2016","unstructured":"Shiels MS, Pfeiffer RM, Besson C, et al.. Trends in primary central nervous system lymphoma incidence and survival in the U.S. Br J Haematol. 2016, 174:417-24. 10.1111\/bjh.14073","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-510x(00)00385-3","article-title":"Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment","volume":"181","author":"Schlegel U","year":"2000","unstructured":"Schlegel U, Schmidt-Wolf I, Deckert M. Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci. 2000, 181:1-12. 10.1016\/s0022-510x(00)00385-3","journal-title":"J Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1309\/FNGC-YEMJ-E3MA-E5L2","article-title":"Diagnostic significance of CD20 and FmC7 expression in B-cell disorders","volume":"120","author":"Delgado J","year":"2003","unstructured":"Delgado J, Matutes E, Morilla A, et al.. Diagnostic significance of CD20 and FmC7 expression in B-cell disorders. Am J Clin Pathol. 2003, 120:754-9. 10.1309\/FNGC-YEMJ-E3MA-E5L2","journal-title":"Am J Clin Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21756","article-title":"The current role of clinical flow cytometry in the evaluation of mature B-cell neoplasms","volume":"96","author":"Seegmiller AC","year":"2019","unstructured":"Seegmiller AC, Hsi ED, Craig FE. The current role of clinical flow cytometry in the evaluation of mature B-cell neoplasms. Cytometry B Clin Cytom. 2019, 96:20-9. 10.1002\/cyto.b.21756","journal-title":"Cytometry B Clin Cytom"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2004.03.005","article-title":"Primary central nervous system lymphoma report of 32 cases and review of the literature","volume":"107","author":"Dubuisson A","year":"2004","unstructured":"Dubuisson A, Kaschten B, L\u00e9nelle J, et al.. Primary central nervous system lymphoma report of 32 cases and review of the literature. Clin Neurol Neurosurg. 2004, 107:55-63. 10.1016\/j.clineuro.2004.03.005","journal-title":"Clin Neurol Neurosurg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy192","article-title":"Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma","volume":"21","author":"Grommes C","year":"2019","unstructured":"Grommes C, Rubenstein JL, DeAngelis LM, Ferreri AJ, Batchelor TT. Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma. Neuro Oncol. 2019, 21:296-305. 10.1093\/neuonc\/noy192","journal-title":"Neuro Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.606","article-title":"A systematic approach to the diagnosis of suspected central nervous system lymphoma","volume":"70","author":"Scott BJ","year":"2013","unstructured":"Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol. 2013, 70:311-9. 10.1001\/jamaneurol.2013.606","journal-title":"JAMA Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11623","article-title":"High incidence of thromboembolism in patients with central nervous system lymphoma","volume":"98","author":"Goldschmidt N","year":"2003","unstructured":"Goldschmidt N, Linetsky E, Shalom E, Varon D, Siegal T. High incidence of thromboembolism in patients with central nervous system lymphoma. Cancer. 2003, 98:1239-42. 10.1002\/cncr.11623","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npw033","article-title":"Case-based review: primary central nervous system lymphoma","volume":"4","author":"Korfel A","year":"2017","unstructured":"Korfel A, Schlegel U, Johnson DR, Kaufmann TJ, Giannini C, Hirose T. Case-based review: primary central nervous system lymphoma. Neurooncol Pract. 2017, 4:46-59. 10.1093\/nop\/npw033","journal-title":"Neurooncol Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004265","article-title":"Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy","volume":"89","author":"Moulignier A","year":"2017","unstructured":"Moulignier A, Lamirel C, Picard H, et al.. Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy. Neurology. 2017, 89:796-804. 10.1212\/WNL.0000000000004265","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70229-1","article-title":"High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG- 1): a phase 3, randomised, non-inferiority trial","volume":"11","author":"Thiel E","year":"2010","unstructured":"Thiel E, Korfel A, Martus P, et al.. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG- 1): a phase 3, randomised, non-inferiority trial. Lancet Oncol. 2010, 11:1036-47. 10.1016\/S1470-2045(10)70229-1","journal-title":"Lancet Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215372","article-title":"Update on novel therapeutics for primary CNS lymphoma","volume":"13","author":"Schaff LR","year":"2021","unstructured":"Schaff LR, Grommes C. Update on novel therapeutics for primary CNS lymphoma. Cancers (Basel). 2021, 13:10.3390\/cancers13215372","journal-title":"Cancers (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos159","article-title":"Surgery for primary CNS lymphoma? Challenging a paradigm","volume":"14","author":"Weller M","year":"2012","unstructured":"Weller M, Martus P, Roth P, Thiel E, Korfel A. Surgery for primary CNS lymphoma? Challenging a paradigm. Neuro Oncol. 2012, 14:1481-4. 10.1093\/neuonc\/nos159","journal-title":"Neuro Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15990","article-title":"A case report on primary central nervous system lymphoma in immunocompetent individual","volume":"13","author":"Mandal S","year":"2021","unstructured":"Mandal S, Shah S, Gami S, Ray B, Poulose J. A case report on primary central nervous system lymphoma in immunocompetent individual. Cureus. 2021, 13:e15990. 10.7759\/cureus.15990","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/90746-a-rare-presentation-of-primary-central-nervous-system-lymphoma-in-an-immunocompetent-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:33Z","timestamp":1707507873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/90746-a-rare-presentation-of-primary-central-nervous-system-lymphoma-in-an-immunocompetent-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.23858","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,5]]}}}